Skip to content

pharmaceuticals.co.nz

Drugs, medicines and medical news
Main navigation

Author: Clinical Editor

Long term benefits of blood pressure lowering . . . and other research

Polypills and heart failureCritics argue that limited dosing options for polypills mean patients get suboptimal care, whereas polypill […]

July 23, 2026 Uncategorized

Popular childhood drinks may raise blood pressure decades later

A 25-year study found that frequent consumption of soda, sports drinks, and fruit juice beginning in childhood was […]

July 23, 2026 Uncategorized

GSK wins US approval for ROS1 lung cancer therapy

GSK wins US approval for ROS1 lung cancer therapy
p p Read More

Jideytro offers option for previously treated patients

July 23, 2026 News

Lundbeck secures FDA Fast Track for narcolepsy drug

Lundbeck secures FDA Fast Track for narcolepsy drug
p p Read More

Designation supports development of novel orexin therapy

July 23, 2026 News

Concordance between target trial emulation and randomised controlled trials: systematic review and meta-analysis

In this paper by Wang and colleagues (BMJ 2026;393:e086810; doi:10.1136/bmj-2025-086810), errors in the supplementary tables and extraction dataset […]

July 23, 2026 Uncategorized

Egg freezing and the privatisation of fertility care

Egg freezing has become increasingly popular in the UK, with an ~45% increase in cycles from 2022 to […]

July 23, 2026 Uncategorized

Advising women about fertility prediction tests and planned oocyte cryopreservation

What you need to knowSensitively discuss individual reproduction goals, assess for factors that might impact fertility, and explain […]

July 23, 2026 Uncategorized

R1 Therapeutics begins global phase 2b trial of AP306 for hyperphosphatemia

R1 Therapeutics begins global phase 2b trial of AP306 for hyperphosphatemia
p p Read More

First patient randomised as study advances novel pan phosphate transporter inhibitor

July 23, 2026 News

Mission Therapeutics divests MTX652 to Dimerix in deal worth up to $292 million

Mission Therapeutics divests MTX652 to Dimerix in deal worth up to 2 million
p p Read More

Move sharpens Mission’s focus on CNS pipeline as renal specialist takes AKI asset forward

July 22, 2026 News

Scientists revive a powerful antibiotic that superbugs had defeated

Scientists have found a way to revive vancomycin, a powerful antibiotic that some dangerous bacteria have learned to […]

July 22, 2026 Uncategorized

Posts navigation

« Previous

Posts pagination

1 2 … 2,017 Next »
Proudly powered by WordPress | Theme: Hive Lite by Pixelgrade.
Footer navigation
  • Privacy Policy